T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation

被引:15
作者
Acuña-Castillo, C
Aravena, M
Leiva-Salcedo, E
Pérez, V
Gómez, C
Sabaj, V
Nishimura, S
Pérez, C
Colombo, A
Walter, R
Sierra, F
机构
[1] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago, Chile
[2] Univ Chile, Fac Med, Ctr FONDAP Estudios Mol Celula, Santiago, Chile
[3] Lankenau Inst Med Res, Wynnewood, PA 19096 USA
关键词
T lymphocytes; cystatins; T-kininogen; signal transduction; cell proliferation;
D O I
10.1016/j.mad.2005.07.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Plasma levels of kininogens increase with age in both rats and humans. Kininogens are inhibitors of cysteine proteinases, and filarial cysteine proteinase inhibitors (cystatins) reduce the proliferation of T cells. We evaluated whether T-kininogen (T-KG) might mimic this effect, and here we present data indicating that exposure of either rat splenocytes or Jurkat cells to purified T-KG results in inhibition of both ERK activation and [H-3]-thymidine incorporation, both basal and in response to ConA or PHA. Interestingly, T-KG did not impair [H-3]-thymidine incorporation in response to IL-2, which requires primarily the activation of the JNK and Jak/STAT pathways. These effects were neither the consequence of increased cell death, nor required the activity of kinin receptors. Furthermore, when T cell receptor proximal events were bypassed by the use of PMA plus Calcium ionophore, T-KG no longer inhibited ERK activation, suggesting that inhibition occurs upstream of these events, possibly at the level of membrane associated signal transduction molecules. We conclude that, like filarial cystatins, T-KG inhibits ERK-dependent T cell proliferation, and these observations suggest a possible role for T-KG in immunosenescence. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1284 / 1291
页数:8
相关论文
共 28 条
[1]  
ANDERSON KP, 1985, J BIOL CHEM, V260, P2065
[2]   T-kininogen can either induce or inhibit proliferation in Balb/c 3T3 fibroblasts, depending on the route of administration [J].
Aravena, M ;
Pérez, C ;
Acuña-Castillo, C ;
Gómez, C ;
Leiva-Salcedo, E ;
Nishimura, S ;
Sabaj, V ;
Walter, R ;
Sierra, F .
MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (03) :399-406
[3]   Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response [J].
Dainichi, T ;
Maekawa, Y ;
Ishii, K ;
Zhang, TQ ;
Nashed, BF ;
Sakai, T ;
Takashima, M ;
Himeno, K .
INFECTION AND IMMUNITY, 2001, 69 (12) :7380-7386
[4]   Alternate signalling pathways from the interleukin-2 receptor [J].
Ellery, JM ;
Nicholls, PJ .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (01) :27-40
[5]   Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging [J].
Glaser, R ;
MacCallum, RC ;
Laskowski, BF ;
Malarkey, WB ;
Sheridan, JF ;
Kiecolt-Glaser, JK .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2001, 56 (08) :M477-M482
[6]   A filarial cysteine protease inhibitor downregulates T cell proliferation and enhances interleukin-10 production [J].
Hartmann, S ;
Kyewski, B ;
Sonnenburg, B ;
Lucius, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2253-2260
[7]  
Kimura Y, 1983, Adv Exp Med Biol, V156 (Pt B), P755
[8]   Analysis of Raf-1 activation in response to TCR activation and costimulation in murine T-lymphocytes: Effect of age [J].
Kirk, CJ ;
Miller, RA .
CELLULAR IMMUNOLOGY, 1998, 190 (01) :33-42
[9]  
KRIUSBEEK AM, 2000, CURRENT PROTOCOLS IM, pCH3
[10]   Therapeutic effects of cysteine protease inhibition in allergic lung inflammation: Inhibition of allergen-specific T lymphocyte migration [J].
Layton, GT ;
Harris, SJ ;
Bland, FA ;
Lee, SR ;
Fearn, S ;
Kaleta, J ;
Wood, ML ;
Bond, A ;
Ward, G .
INFLAMMATION RESEARCH, 2001, 50 (08) :400-408